Anti-inflammatory drug

Arthritis drug improves survival in critically ill COVID patients

Boston: Anti-inflammatory drug tocilizumab has been shown to reduce mortality by 30 per cent among critically ill COVID-19 patients when administered within the first two days of hospitalisation, according to a study…